List of Contents

Biopsy Needle Market Size, Share, and Trends 2024 to 2034

Biopsy Needle Market (By Product: Biopsy Needle Guns, Biopsy Needles; By Application: Cancer, Autoimmune Disorder, Infectious Diseases, Others; By End-use: Hospitals, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2034

  • Last Updated : July 2024
  • Report Code : 4085
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biopsy Needle Market 

5.1. COVID-19 Landscape: Biopsy Needle Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopsy Needle Market, By Product

8.1. Biopsy Needle Market Revenue and Volume, by Product, 2024-2034

8.1.1 Biopsy Needle Guns

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Biopsy Needles

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Biopsy Needle Market, By Application

9.1. Biopsy Needle Market Revenue and Volume, by Application, 2024-2034

9.1.1. Cancer

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Autoimmune Disorder

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Infectious Diseases

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Others

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Biopsy Needle Market, By End-use 

10.1. Biopsy Needle Market Revenue and Volume, by End-use, 2024-2034

10.1.1. Hospitals

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Biopsy Needle Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.1.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.1.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.2.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.2.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.3.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.3.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.6.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.6.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.4.7.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.4.7.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.4.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.4.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

11.5.5.2. Market Revenue and Volume Forecast, by Application (2021-2034)

11.5.5.3. Market Revenue and Volume Forecast, by End-use (2021-2034)

Chapter 12. Company Profiles

12.1. Becton

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Medtronic Plc

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Cardinal Health

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Hologic Inc

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Olympus Corporation

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Argon Medical Devices Inc

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Devicor Medical Products, Inc

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. B. Braun Melsungen AG

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Cook Group Incorporated

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Boston Scientific Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global biopsy needle market size is expected to increase USD 2.82 billion by 2034 from USD 1.30 billion in 2023.

The global biopsy needle market will register growth rate of 7.3% between 2024 and 2034.

The major players operating in the biopsy needle market are Becton, Medtronic Plc, Cardinal Health, Hologic Inc, Olympus Corporation, Argon Medical Devices Inc, Devicor Medical Products, Inc, B. Braun Melsungen AG, Cook Group Incorporated, Boston Scientific Corporation, FUJIFILM Holdings Corporation, Dickinson and Company, Stryker Corporation, INRAD, Inc, and Others.

The driving factors of the biopsy needle market are the number of people suffering from cancer has increased rapidly and increasing preference for minimal invasive procedures (MIP).

North America region will lead the global biopsy needle market during the forecast period 2024 to 2034.

Proceed To Buy

USD 5400
USD 3800
USD 2100
USD 2100
USD 7500
Immediate Delivery Available

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client

down-arrow-imgGet a Sample

Connect with us now; your solution awaits on the other side!

Contact Us